Why the study?
Does flurbiprofen or subcutaneous heparin prevent deep vein thrombosis in patients following acute myocardial infarction?
Does flurbiprofen or subcutaneous heparin prevent deep vein thrombosis in patients following acute myocardial infarction?
The low incidence of deep vein thrombosis following acute myocardial infarction, possibly due to early ambulation, suggests a need to reassess routine prophylactic anticoagulant therapy.
No takes yet. Share an insight, caveat, or question.
Low post-MI DVT rates preclude flurbiprofen efficacy assessment; challenges routine prophylaxis and supports reassessment with early ambulation.
Pitney et al. (1980) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: